ArticleJournal of immunological methods2021

Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodies.

Rachael E Whaley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.